Timing of insertion affects expulsion in patients using the levonorgestrel 52 mg intrauterine system for noncontraceptive indications

Sara Harris,Bliss Kaneshiro,Hyeong Jun Ahn,Lynne Saito-Tom
DOI: https://doi.org/10.1016/j.contraception.2020.11.012
IF: 3.051
2021-03-01
Contraception
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>: To evaluate levonorgestrel 52 mg intrauterine system (IUS) expulsion risk by menstrual cycle day of insertion (days 1-8 vs. days 9 and beyond) in women using the IUS for non-contraceptive indications.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Study Design</h3><p>: We performed a retrospective cohort study of patients with a levonorgestrel IUS inserted for the management of non-contraceptive, gynecologic conditions at Kaiser Permanente-Hawaii between January 2009 and December 2010. We used multivariable logistic regression models to estimate the likelihood of IUS expulsion adjusting for demographic and clinical factors and a Kaplan-Meier curve for survival analysis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>: Of 176 patients identified, insertion occurred in 42 patients in cycle days 1-8 and 87 patients after day 8. Patient follow-up within the Kaiser system ranged from 1-71 months. Thirty-nine (22%) patients experienced expulsion, 16 (38%) and 15 (17%) for the two timing groups, respectively. Expulsion was more likely if the IUS placement occurred during the menstrual cycle days 1-8 (aOR 3.57 [95% CI 1.13, 11.31]), which was consistent with the Kaplan-Meier analysis (p=0.008).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>: Levonorgestrel IUS expulsion among women using the IUS for non-contraceptive indications occurred more frequently if insertion occurred during the first eight days of the menstrual cycle.</p><p><strong>I</strong></p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">mplications</h3><p>: In women planning to use the levonorgestrel IUS to treat gynecologic conditions such as abnormal uterine bleeding, dysmenorrhea, and endometrial hyperplasia, providers should consider waiting until after cycle day 8 to perform insertion.</p>
obstetrics & gynecology
What problem does this paper attempt to address?